-
1
Short‐Course Blinatumomab Treatment as a Bridge to Further Salvage Therapy for Relapsed/Refractory B‐Cell Acute Lymphoblastic Leukemia: A Retrospective Single‐Center Study
Published 2024-12-01Subjects: “…B‐cell acute lymphoblastic leukemia…”
Get full text
Article -
2
Prominent efficacy and good safety of sequential CD19 and CD22 CAR-T therapy in relapsed/refractory adult B-cell acute lymphoblastic leukemia
Published 2025-01-01Subjects: “…Relapsed/refractory B-cell acute lymphoblastic leukemia…”
Get full text
Article